K232316

Substantially Equivalent

DEKA Infusion System, DEKA Administration Set

Applicant: Deka Research and Development
Product code: LDR
Advisory panel: General Hospital
Date received: 2023-08-03
Decision date: 2024-03-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Manchester, NH, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.